Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis

Research output: Contribution to journalEditorial

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)951-952
Number of pages2
JournalChest
Volume151
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Idiopathic Pulmonary Fibrosis
Mesenchymal Stromal Cells
Safety

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis. / Limper, Andrew Harold.

In: Chest, Vol. 151, No. 5, 01.05.2017, p. 951-952.

Research output: Contribution to journalEditorial

@article{5f396a764d0e4e7db8fe998c488a05ea,
title = "Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis",
author = "Limper, {Andrew Harold}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.chest.2016.12.015",
language = "English (US)",
volume = "151",
pages = "951--952",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "5",

}

TY - JOUR

T1 - Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis

AU - Limper, Andrew Harold

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85019116345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019116345&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2016.12.015

DO - 10.1016/j.chest.2016.12.015

M3 - Editorial

VL - 151

SP - 951

EP - 952

JO - Chest

JF - Chest

SN - 0012-3692

IS - 5

ER -